Krsnaa Diagnostics Limited (NSE:KRSNAA) — Market Cap & Net Worth
Market Cap & Net Worth: Krsnaa Diagnostics Limited (KRSNAA)
Krsnaa Diagnostics Limited (NSE:KRSNAA) has a market capitalization of $206.54 Million (Rs19.10 Billion) as of May 2, 2026. Listed on the NSE stock exchange, this India-based company holds position #16412 globally and #832 in its home market, demonstrating a -2.61% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Krsnaa Diagnostics Limited's stock price Rs588.75 by its total outstanding shares 32438672 (32.44 Million). Analyse Krsnaa Diagnostics Limited (KRSNAA) cash conversion ratio to see how efficiently the company converts income to cash.
Krsnaa Diagnostics Limited Market Cap History: 2021 to 2026
Krsnaa Diagnostics Limited's market capitalization history from 2021 to 2026. Data shows change from $255.56 Million to $206.54 Million (-10.16% CAGR).
Index Memberships
Krsnaa Diagnostics Limited is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY MICROCAP 250
NIFTYMICROCAP250
|
$143.76 Billion | 0.14% | #175 of 250 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$3.20 Trillion | 0.01% | #562 of 750 |
Weight: Krsnaa Diagnostics Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Krsnaa Diagnostics Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Krsnaa Diagnostics Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.04x
Krsnaa Diagnostics Limited's market cap is 0.04 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.33x
Krsnaa Diagnostics Limited's market cap is 0.33 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $255.56 Million | $3.96 Billion | $1.85 Billion | 0.06x | 0.14x |
| 2022 | $160.50 Million | $4.55 Billion | $683.88 Million | 0.04x | 0.23x |
| 2023 | $246.88 Million | $4.87 Billion | $621.11 Million | 0.05x | 0.40x |
| 2024 | $310.64 Million | $6.20 Billion | $568.37 Million | 0.05x | 0.55x |
| 2025 | $253.06 Million | $7.17 Billion | $776.08 Million | 0.04x | 0.33x |
Competitor Companies of KRSNAA by Market Capitalization
Companies near Krsnaa Diagnostics Limited in the global market cap rankings as of May 2, 2026.
Key companies related to Krsnaa Diagnostics Limited by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #126 globally with a market cap of $176.29 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #189 globally with a market cap of $123.72 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #578 globally with a market cap of $45.31 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #643 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #126 | Thermo Fisher Scientific Inc | NYSE:TMO | $176.29 Billion | $469.21 |
| #189 | Danaher Corporation | NYSE:DHR | $123.72 Billion | $175.15 |
| #578 | IDEXX Laboratories Inc | NASDAQ:IDXX | $45.31 Billion | $567.46 |
| #643 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
Krsnaa Diagnostics Limited Historical Marketcap From 2021 to 2026
Between 2021 and today, Krsnaa Diagnostics Limited's market cap moved from $255.56 Million to $ 206.54 Million, with a yearly change of -10.16%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs206.54 Million | -18.38% |
| 2025 | Rs253.06 Million | -18.54% |
| 2024 | Rs310.64 Million | +25.83% |
| 2023 | Rs246.88 Million | +53.82% |
| 2022 | Rs160.50 Million | -37.20% |
| 2021 | Rs255.56 Million | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Krsnaa Diagnostics Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $206.54 Million USD |
| MoneyControl | $206.54 Million USD |
| MarketWatch | $206.54 Million USD |
| marketcap.company | $206.54 Million USD |
| Reuters | $206.54 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited provides diagnostic services in India. It offers a range radiology services, including computed tomography scans, magnetic resonance imaging, X-rays, and ultrasound and advanced imaging; pathology services, such as laboratory, and home collection and preventive health; and teleradiology and telepathology services. The company also provides other diagnostics services, su… Read more